Marie Svensson

CFO
  • Independent in relation to the Company and its management: No
  • Independent in relation to major shareholders: Yes
  • Holdings in Alligator: 48,000 shares and 250,000 warrants in program TO 2022/2025 I.
  • Other current positions: Board member of A Bioscience Incentive AB and Atlas Therapeutics AB

Marie Svensson – born 1964, Chief Financial Officer since 2020 – has a Bachelor of Science in accounting and a Master of Business Administration/Management from Lund University. Marie has more than 20 years of experience from various financial positions in the high-tech industry. Employed since 2020 and member of the Management Team since 2020.

Updated 2022-07-21